ACI

Analyst Note: ACI (Albertsons Companies, Inc.)

Date: 2026-06-13 Current Price: $13.45

1. Structural Readiness

• Conservative Entry: Not actionable at this time. A conservative entry requires a confirmed breakout above the resistance level defined by the coil's upper boundary.
• Aggressive/Pre-Breakout Entry: Not recommended as a standalone signal. While the structure is intact, the "forming" state represents a partial readiness signal (historically ~69% success rate for forming coils that eventually break out), but it lacks the confirmation of a breakout.
• Breakout Level: Not defined in the provided evidence.
• Current Price: $13.45.
• Extension: Not applicable (price is not extending above a breakout level).
• ATR Context: Current ATR is 4.0% (High). This falls within the historical "sweet spot" (4–6%) for structural quality, suggesting the stock has sufficient volatility to support a move but is not in the "extreme" (>8%) danger zone for severe losers.

2. Thesis Layer

• Thesis Status: Tactical / Setup-Led.
• Macro Thesis: There is no named secular thesis attached to this name as of 2026-06-13.
• Judgment Framework: The investment case must be judged strictly on the quality of the technical setup (the forming coil) and the underlying business fundamentals (EBITDA growth, digital adoption, loyalty expansion). No macro narratives or "secular themes" should be invented to bolster the conviction. The setup quality and business health are the sole drivers.

3. The Business

Albertsons Companies, Inc. operates as one of the largest food and drug retailers in the United States, serving approximately 36.5 million customers per week.

• Operational Footprint: As of February 28, 2026, the company operated 2,244 stores across 35 states and the District of Columbia. The network includes 1,708 pharmacies, 1,241 in-store branded coffee shops, 404 fuel centers, 22 distribution centers, and 19 manufacturing facilities.
• Banners: The company operates 22 well-known banners, including Albertsons, Safeway, Vons, Pavilions, Randalls, Tom Thumb, Carrs, Jewel-Osco, ACME, Shaw's, Star Market, United Supermarkets, Market Street, Haggen, Kings Food Markets, and Balducci's.
• Financial Performance (Fiscal 2025 Context):
• Sales Growth: Net sales increased 2.2% to $62.9 billion for the first 40 weeks of fiscal 2025. Identical sales (excluding fuel) increased 2.4% in Q3 fiscal 2025.
• Digital Adoption: Digital sales (Drive Up & Go, home delivery) increased 21% in Q3 fiscal 2025. Delivery is offered in >2,200 stores, and curbside pickup in >2,100 stores.
• Loyalty: The membership program grew 12% to 51.2 million members (as of Feb 2026), with higher spending among engaged households.
• Own Brands: Retail sales of Own Brands products reached $16.9 billion in fiscal 2025.
• Management Expectations (Recorded as of April 14, 2026):
• EBITDA: Expected to be $3.85B – $3.925B (approx. 2.5% growth at the top end, excluding 53rd-week impact).
• Identical Sales: Expected to be 0% to 1% or 1.5% to 2.5%, assuming near-flat pharmacy sales and excluding a 150 bps headwind from the IRA.
• EPS: Expected to be $2.22 – $2.32, including $600 million in share repurchases.
• Capex: Expected to be $2.0B – $2.2B to accelerate investment in new stores, remodels, AI, and digital capabilities.
• Productivity: Management reset productivity targets to $2 billion over the next 3 years.

4. Archetype and Conviction

• Archetype: Quality Compounder.
• *Fit:* The company demonstrates consistent revenue growth (2.2% net sales, 2.4% identical sales), strong digital acceleration (21% digital growth), and a massive, engaged loyalty base (51.2M members). The management's commitment to capital returns ($600M buybacks) and productivity improvements ($2B target) aligns with a compounder profile focused on operational efficiency and shareholder return.
• Valuation Context:
• Forward consensus EPS (FY1) is $2.13, and FY2 is $2.28.
• At a current price of $13.45, the stock trades at approximately 6.3x FY1 EPS and 5.9x FY2 EPS. This suggests a valuation that is not pricing in significant multiple expansion, relying instead on earnings delivery.
• Conviction Stack:
• Thesis Strength: Low (No named macro thesis; purely tactical).
• Evidence Quality: High. The evidence base is robust, covering earnings transcripts, SEC filings, and financial spines with specific, quantified figures.
• Setup Readiness: Partial. The coil is forming, which is a positive signal, but it is not yet actionable as a confirmed breakout.
• Rerating Potential: Dependent on the successful execution of the $2B productivity target and the continuation of digital growth.

5. Invalidations, Strengtheners, and Gaps

• Strengtheners: A confirmed breakout above the coil's resistance level (price action) combined with management reaffirming the $2B productivity target or accelerating digital sales growth would strengthen the case.
• Gaps in Evidence:
• Breakout Level: The specific resistance level required for a confirmed breakout is not defined.
• Debt/Capital Structure: While Capex and buybacks are mentioned, specific details on net debt levels or interest coverage ratios are not explicitly detailed in the provided evidence snippets.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Sizing hint: Position size should be minimal or zero until a confirmed breakout occurs; current setup is a watch-list candidate, not an entry signal. Expected horizon: 3 to 6 months for the setup to resolve into a confirmed breakout or invalidation.